HIGHLAND PEAK CAPITAL, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1961320
OLD GREENWICH, CT
Position in TEVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,672,386
+$5,987,258 QoQ
Shares Held
551,133
+30.9% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
5.43%
of 13F equity value
Holder Rank
#107
of 673 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Mar 31, 2026CallValue
$6,024,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HIGHLAND PEAK CAPITAL, LLC holds $36,167,874 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (51.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
551,133 | $18,672,386 | |
| 2 | VTRS |
Viatris Inc
|
1,101,731 | $17,495,488 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,672,386 | 551,133 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $12,685,128 | 421,153 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $6,024,000 | 200,000 | Call | Sole | 2026-05-13 | |
| 2025-12-31 | $13,783,553 | 441,639 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,590,457 | 573,785 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,981,571 | 655,225 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||